1-235448220-CAAAAAAAAAAAAAA-CAAAAAAAAAAAAAAAAAAA

Variant summary

Our verdict is . The variant received 0 ACMG points: 0P and 0B.

The NM_152490.5(B3GALNT2):​c.*1981_*1985dupTTTTT variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00045 in 530,564 control chromosomes in the GnomAD database, with no homozygous occurrence. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.00049 ( 0 hom., cov: 24)
Exomes 𝑓: 0.00045 ( 0 hom. )

Consequence

B3GALNT2
NM_152490.5 3_prime_UTR

Scores

Not classified

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -2.40

Publications

0 publications found
Variant links:
Genes affected
B3GALNT2 (HGNC:28596): (beta-1,3-N-acetylgalactosaminyltransferase 2) This gene encodes a member of the glycosyltransferase 31 family. The encoded protein synthesizes GalNAc:beta-1,3GlcNAc, a novel carbohydrate structure, on N- and O-glycans. Alternatively spliced transcript variants that encode different isoforms have been described. [provided by RefSeq, Mar 2013]
TBCE (HGNC:11582): (tubulin folding cofactor E) Cofactor E is one of four proteins (cofactors A, D, E, and C) involved in the pathway leading to correctly folded beta-tubulin from folding intermediates. Cofactors A and D are believed to play a role in capturing and stabilizing beta-tubulin intermediates in a quasi-native confirmation. Cofactor E binds to the cofactor D/beta-tubulin complex; interaction with cofactor C then causes the release of beta-tubulin polypeptides that are committed to the native state. Two transcript variants encoding the same protein have been found for this gene. [provided by RefSeq, Jul 2008]
TBCE Gene-Disease associations (from GenCC):
  • hypoparathyroidism-retardation-dysmorphism syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, Orphanet, G2P, Labcorp Genetics (formerly Invitae)
  • early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • encephalopathy, progressive, with amyotrophy and optic atrophy
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, PanelApp Australia, ClinGen, Ambry Genetics
  • autosomal recessive Kenny-Caffey syndrome
    Inheritance: AR Classification: MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_152490.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152490.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GALNT2
NM_152490.5
MANE Select
c.*1981_*1985dupTTTTT
3_prime_UTR
Exon 12 of 12NP_689703.1Q8NCR0-1
TBCE
NM_003193.5
MANE Select
c.1400-113_1400-109dupAAAAA
intron
N/ANP_003184.1Q15813-1
TBCE
NM_001287801.2
c.1553-113_1553-109dupAAAAA
intron
N/ANP_001274730.1Q15813-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
B3GALNT2
ENST00000366600.8
TSL:1 MANE Select
c.*1981_*1985dupTTTTT
3_prime_UTR
Exon 12 of 12ENSP00000355559.3Q8NCR0-1
TBCE
ENST00000642610.2
MANE Select
c.1400-113_1400-109dupAAAAA
intron
N/AENSP00000494796.1Q15813-1
ENSG00000285053
ENST00000647186.1
c.1400-113_1400-109dupAAAAA
intron
N/AENSP00000494775.1

Frequencies

GnomAD3 genomes
AF:
0.000489
AC:
32
AN:
65480
Hom.:
0
Cov.:
24
show subpopulations
Gnomad AFR
AF:
0.000624
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000530
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000630
Gnomad FIN
AF:
0.000403
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000430
Gnomad OTH
AF:
0.00117
GnomAD4 exome
AF:
0.000445
AC:
207
AN:
465066
Hom.:
0
AF XY:
0.000436
AC XY:
110
AN XY:
252054
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00232
AC:
26
AN:
11218
American (AMR)
AF:
0.000165
AC:
4
AN:
24284
Ashkenazi Jewish (ASJ)
AF:
0.000586
AC:
9
AN:
15350
East Asian (EAS)
AF:
0.0000708
AC:
2
AN:
28248
South Asian (SAS)
AF:
0.000457
AC:
24
AN:
52476
European-Finnish (FIN)
AF:
0.0000678
AC:
2
AN:
29510
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2968
European-Non Finnish (NFE)
AF:
0.000456
AC:
126
AN:
276066
Other (OTH)
AF:
0.000561
AC:
14
AN:
24946
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.273
Heterozygous variant carriers
0
22
44
67
89
111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000489
AC:
32
AN:
65498
Hom.:
0
Cov.:
24
AF XY:
0.000491
AC XY:
15
AN XY:
30530
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000624
AC:
13
AN:
20840
American (AMR)
AF:
0.000529
AC:
3
AN:
5674
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1634
East Asian (EAS)
AF:
0.00
AC:
0
AN:
1664
South Asian (SAS)
AF:
0.000634
AC:
1
AN:
1578
European-Finnish (FIN)
AF:
0.000403
AC:
1
AN:
2484
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
126
European-Non Finnish (NFE)
AF:
0.000429
AC:
13
AN:
30268
Other (OTH)
AF:
0.00115
AC:
1
AN:
868
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000536942), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.366
Heterozygous variant carriers
0
2
4
6
8
10
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
2

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-2.4

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.